Impurity D
|
非奈利酮雜質(zhì)D
|
2640280-83-5
|
(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-nitrophenyl carbonate
|
(5-甲基-2-氧代-1,3-二氧雜環(huán)戊烯-4-基)甲基 4-硝基苯基碳酸酯
|
173604-87-0
|
Cabotegravir (GSK744, GSK1265744)
|
卡博特韋
|
1051375-10-0
|
biphenyl-2-yl-carbamic acid 1-[2-(benzylmethylamino)ethyl]piperidin-4-yl ester
|
雷芬那辛中間體
|
864686-28-2
|
Baloxavir
|
巴洛沙韋
|
1985605-59-1
|
(2S-trans)-3-Amino-2-methyl-4-oxoazetidine-1-sulphonic acid
|
氨曲南主環(huán)
|
80082-65-1
|
2-Mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl) isopropoxyiminoacetate
|
頭孢他啶側(cè)鏈酸活性酯
|
89604-92-2
|
N-[1,1'-biphenyl]-2-yl-, 1-[2-[[4-(hydroxymethyl)benzoyl]methylamino]ethyl]-4-piperidinyl ester
|
雷芬那辛雜質(zhì)F
|
1682660-39-4
|
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid ethyl ester
|
加替環(huán)內(nèi)酯
|
112811-71-9
|
Moxifloxacin hydrochloride
|
鹽酸莫西沙星
|
186826-86-8
|
4-piperidyl N-(2-biphenyl)carbamate
|
雷芬那辛 中間體
|
171722-92-2
|
1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-1,4-dihydro-5-methoxy-2,8-dimethyl-
|
非奈利酮雜質(zhì)G
|
2640280-86-8
|
1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-1,4-dihydro-2,8-dimethyl-5-(1-methylethoxy)-
|
非奈利酮雜質(zhì)J
|
2640280-87-9
|
Avibactam Sodium impurities G
|
阿維巴坦鈉雜質(zhì)G,(2S,5R)-7-氧代-N-磺酸基-6-磺酸氧基-1,6-二氮雜雙環(huán)[3.2.1]辛烷-2-甲酰胺二鈉鹽
|
|
Benzoic acid, 4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]-
|
雷芬那辛雜質(zhì)A
|
938143-02-3
|
5-deazaflavin
|
脫氮黃素
|
26908-38-3
|
2-(N-benzyl-N-methylamino)ethyl chloride hydrochloride
|
N-(2-氯乙基)-N-甲基芐胺鹽酸鹽
|
23510-18-1
|
Upadacitinib
|
烏帕替尼
|
1310726-60-3
|
Revefenacin
|
雷芬那辛
|
864750-70-9
|
4-Benzoylmorpholine
|
4-苯甲酰嗎啉
|
1468-28-6
|
Impurity A
|
非奈利酮雜質(zhì)A
|
2640280-82-4
|
(2S,5R)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide 7-oxo-6-(sulfoxy)monosodium salt
|
阿維巴坦鈉
|
1192491-61-4
|
Ivabradine IMpurity
|
伊伐布雷定雜質(zhì)
|
1616710-50-9
|
Finerenone (BAY 94-8862)
|
非奈利酮
|
1050477-31-0
|
1-(2-(methylamino)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate
|
雷芬那辛 中間體
|
743460-48-2
|
ZVPVPYWMFMUFEZ-UHFFFAOYSA-N
|
1-(4-((2-(4-([1,1'-聯(lián)苯]-2-基氨甲酰)氧基)哌啶-1-基)乙基(甲基)氨甲酰)芐基)哌啶-4-羧酸
|
909800-36-8
|
Rotigotine;;(6S)-6-{propyl[2-(thiophen-2-yl)ethyl]amino}-5,6,7,8-tetrahydronaphthalen-1-ol
|
羅替戈??; (S)-5,6,7,8-四氫-6-(丙基(2-(2-噻吩基)乙基)氨基)-1-萘酚
|
99755-59-6
|
1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-
|
非奈利酮雜質(zhì)K
|
2084136-51-4
|
1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-1,4-dihydro-5-methoxy-2,8-dimethyl-
|
非奈利酮雜質(zhì)E
|
2640280-84-6
|
vericiguat
|
維利西呱
|
1350653-20-1
|
4,4'-Dimethylbiphenyl
|
4,4'-二甲基聯(lián)苯
|
613-33-2
|
2-Benzoylpyrrole
|
7697-46-3
|
1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-1,4-dihydro-2,8-dimethyl-5-(1-methylethoxy)-
|
非奈利酮雜質(zhì)F
|
2640280-85-7
|
LeterMovir
|
萊特莫韋
|
917389-32-3
|
lifitegrast;;(S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6- carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoic
|
立他司特;;(S)-2-[2-(苯并呋喃-6-羰基)-5,7-二氯-1,2,3,4-四氫異喹啉-6-甲酰胺基]-3-(3-甲磺?;交?丙酸
|
1025967-78-5
|
Larotrectinib
|
硫酸拉羅替尼
|
1223405-08-0
|
N-benzyl-2-chloro-N-methyl-ethanamine
|
N-芐基-2-氯-N-甲基乙胺
|
17542-47-1
|